These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 1653186)

  • 21. N-acetyl-L-cysteine potentiates depressor response to captopril and enalaprilat in SHRs.
    Ruiz FJ; Salom MG; Inglés AC; Quesada T; Vicente E; Carbonell LF
    Am J Physiol; 1994 Sep; 267(3 Pt 2):R767-72. PubMed ID: 8092321
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Protective effects of sulfhydryl-containing angiotensin converting enzyme inhibitors against free radical injury in endothelial cells.
    Mak IT; Freedman AM; Dickens BF; Weglicki WB
    Biochem Pharmacol; 1990 Nov; 40(9):2169-75. PubMed ID: 2173602
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of angiotensin-converting enzyme inhibitors on human neutrophil chemotaxis in vitro.
    Clapperton M; McMurray J; Fisher AC; Dargie HJ
    Br J Clin Pharmacol; 1994 Jul; 38(1):53-6. PubMed ID: 7946937
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Captopril scavenges hydrogen peroxide and reduces, but does not eliminate, oxidant-induced cell injury.
    Andreoli SP
    Am J Physiol; 1993 Jan; 264(1 Pt 2):F120-7. PubMed ID: 8381600
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Angiotensin-converting enzyme inhibition preserves endothelium-dependent coronary microvascular responses during short-term ischemia-reperfusion.
    Piana RN; Wang SY; Friedman M; Sellke FW
    Circulation; 1996 Feb; 93(3):544-51. PubMed ID: 8565174
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacological evidence that captopril possesses an endothelium-mediated component of vasodilation: effect of sulfhydryl groups on endothelium-derived relaxing factor.
    Goldschmidt JE; Tallarida RJ
    J Pharmacol Exp Ther; 1991 Jun; 257(3):1136-45. PubMed ID: 1646324
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dietary sodium restriction specifically potentiates left ventricular ACE inhibition by zofenopril, and is associated with attenuated hypertrophic response in rats with myocardial infarction.
    Westendorp B; Schoemaker RG; Buikema H; de Zeeuw D; van Veldhuisen DJ; van Gilst WH
    J Renin Angiotensin Aldosterone Syst; 2004 Mar; 5(1):27-32. PubMed ID: 15136971
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential influences of angiotensin converting-enzyme inhibitors on the coronary circulation.
    van Gilst WH; Scholtens E; de Graeff PA; de Langen CD; Wesseling H
    Circulation; 1988 Jun; 77(6 Pt 2):I24-9. PubMed ID: 3286044
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Captopril and enalaprilat do not scavenge the superoxide anion.
    Kukreja RC; Kontos HA; Hess ML
    Am J Cardiol; 1990 May; 65(19):24I-27I. PubMed ID: 2159692
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cellular mechanisms of captopril-induced matrix remodeling in Syrian hamster cardiomyopathy.
    Davison G; Hall CS; Miller JG; Scott M; Wickline SA
    Circulation; 1994 Sep; 90(3):1334-42. PubMed ID: 8087943
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structural details on the binding of antihypertensive drugs captopril and enalaprilat to human testicular angiotensin I-converting enzyme.
    Natesh R; Schwager SL; Evans HR; Sturrock ED; Acharya KR
    Biochemistry; 2004 Jul; 43(27):8718-24. PubMed ID: 15236580
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hydrochlorothiazide increases plasma or tissue angiotensin-converting enzyme-inhibitor drug levels in rats with myocardial infarction: differential effects on lisinopril and zofenopril.
    Westendorp B; Schoemaker RG; van Gilst WH; van Veldhuisen DJ; Buikema H
    Eur J Pharmacol; 2005 Dec; 527(1-3):141-9. PubMed ID: 16310764
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetic and pharmacodynamic comparative study of zofenopril and enalapril in healthy volunteers.
    Marzo A; Dal Bo L; Mazzucchelli P; Monti NC; Crivelli F; Ismaili S; Giusti A; Uhr MR
    Arzneimittelforschung; 2002; 52(4):233-42. PubMed ID: 12040965
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of angiotensin-converting-enzyme inhibitors in combination with diuretics on blood pressure and renal injury in nitric oxide-deficiency-induced hypertension in rats.
    García-Estañ J; Ortiz MC; O'Valle F; Alcaraz A; Navarro EG; Vargas F; Evangelista S; Atucha NM
    Clin Sci (Lond); 2006 Feb; 110(2):227-33. PubMed ID: 16197366
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term clinical experience with zofenopril.
    Borghi C; Bacchelli S; Degli Esposti D
    Expert Rev Cardiovasc Ther; 2012 Aug; 10(8):973-82. PubMed ID: 23030285
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Zofenopril inhibits the expression of adhesion molecules on endothelial cells by reducing reactive oxygen species.
    Cominacini L; Pasini A; Garbin U; Evangelista S; Crea AE; Tagliacozzi D; Nava C; Davoli A; LoCascio V
    Am J Hypertens; 2002 Oct; 15(10 Pt 1):891-5. PubMed ID: 12372676
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The direct effects of the angiotensin-converting enzyme inhibitors, zofenoprilat and enalaprilat, on isolated human pancreatic islets.
    Lupi R; Del Guerra S; Bugliani M; Boggi U; Mosca F; Torri S; Del Prato S; Marchetti P
    Eur J Endocrinol; 2006 Feb; 154(2):355-61. PubMed ID: 16452552
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition by converting enzyme inhibitors of pig kidney aminopeptidase P.
    Hooper NM; Hryszko J; Oppong SY; Turner AJ
    Hypertension; 1992 Mar; 19(3):281-5. PubMed ID: 1312513
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy of Zofenopril vs. Irbesartan in Combination with a Thiazide Diuretic in Hypertensive Patients with Multiple Risk Factors not Controlled by a Previous Monotherapy: A Review of the Double-Blind, Randomized "Z" Studies.
    Omboni S; Malacco E; Napoli C; Modesti PA; Manolis A; Parati G; Agabiti-Rosei E; Borghi C
    Adv Ther; 2017 Apr; 34(4):784-798. PubMed ID: 28260186
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Captopril inhibits peptidylglycine- alpha-hydroxylating monooxygenase: implications for therapeutic effects.
    Mueller SA; Driscoll WJ; Mueller GP
    Pharmacology; 1999 May; 58(5):270-80. PubMed ID: 10087468
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.